Clincosm LogoSign in Get a demo

Tuberculosis, Pulmonary

Showing 76 - 100 of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Pulmonary, Antibiotic Prophylaxis Trial in Dourados (Isoniazid 900 milligrams, Placebo)

Terminated
Has Results
  • Tuberculosis, Pulmonary
  • Antibiotic Prophylaxis
  • Isoniazid 900 milligrams
  • Placebo
  • Dourados, Mato Grosso Do Sul, Brazil
    Roberto Oliveira
Oct 2, 2019

Tuberculosis, Pulmonary, Non-Tuberculous Mycobacterial Pneumonia, Lung Cancer Trial

Completed
  • Tuberculosis, Pulmonary
  • +3 more
    • (no location specified)
    Sep 3, 2019

    Tuberculosis, Pulmonary Trial in Shanghai (CRISPR-based Test)

    Unknown status
    • Tuberculosis, Pulmonary
    • CRISPR-based Test
    • Shanghai, Shanghai, China
      Huashan Hospital
    Aug 28, 2019

    Tuberculosis, Tuberculosis, Pulmonary, Cavity Trial in Ulsan (Observation of AFB smear/culture)

    Completed
    • Tuberculosis
    • +7 more
    • Observation of AFB smear/culture
    • Ulsan, Korea, Republic of
      Ulsan University Hospital, 877 Bangeojin Sunwhando-ro
    Jun 23, 2019

    Tuberculosis, Pulmonary Trial in Beijing (New management mode intervention)

    Unknown status
    • Tuberculosis, Pulmonary
    • New management mode intervention
    • Beijing, Beijing, China
      Beijing Chest Hospital
    May 28, 2019

    Tuberculosis, Tuberculosis, Pulmonary Trial in Baltimore (Rifampin & midazolam, rifapentine & midazolam, rifapentine and

    Completed
    Has Results
    • Tuberculosis
    • Tuberculosis, Pulmonary
    • Rifampin & midazolam
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University
    Jan 29, 2019

    Tuberculosis, Pulmonary Trial (VDOT, VDOT + mobile money)

    Unknown status
    • Tuberculosis, Pulmonary
    • VDOT
    • VDOT + mobile money
    • (no location specified)
    Apr 27, 2019

    Tuberculosis, Pulmonary Trial in Worldwide (Rifampicin, Isoniazid, Pyrazinamide)

    Unknown status
    • Tuberculosis, Pulmonary
    • Bandung, Indonesia
    • +13 more
    Apr 18, 2019

    Tuberculosis, Pulmonary Trial in Torino

    Unknown status
    • Tuberculosis, Pulmonary
      • Torino, Italy
        Ospedale Amedeo di Savoia
      Apr 16, 2019

      Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections Trial in Neu-Ulm (BTZ-043, Placebo)

      Completed
      • Tuberculosis
      • +4 more
      • Neu-Ulm, Bavaria, Germany
        Nuvisan
      Mar 6, 2019

      Tuberculosis, Pulmonary, HIV/AIDS Trial in Manaus (RIPE (2m) and RI (4m), RIPE+NAC (2m) and RI (4m))

      Unknown status
      • Tuberculosis, Pulmonary
      • HIV/AIDS
      • RIPE (2m) and RI (4m)
      • RIPE+NAC (2m) and RI (4m)
      • Manaus, Amazonas, Brazil
        Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
      Feb 12, 2019

      Tuberculosis, Tuberculosis, Pulmonary Trial in San Antonio (TBA-7371, Placebo)

      Completed
      • Tuberculosis
      • Tuberculosis, Pulmonary
      • San Antonio, Texas
        Worldwide Clinical Trials
      Oct 16, 2018

      Tuberculosis, Tuberculosis, Pulmonary Trial in Lausanne (PBTZ169 Formulation, Placebo, PBTZ169 NCP)

      Completed
      • Tuberculosis
      • Tuberculosis, Pulmonary
      • PBTZ169 Formulation
      • +2 more
      • Lausanne, Vaud, Switzerland
        Division of Clinical Pharmacology, Centre Hospitalier Universita
      Jul 12, 2018

      Tuberculosis, Pulmonary, AIDS Trial in Shanghai (Rifampicin, Rifabutin)

      Unknown status
      • Tuberculosis, Pulmonary
      • AIDS
      • Shanghai, Shanghai, China
        Shanghai Public Health Clinical Center
      Apr 23, 2018

      MDR-TB and Second-Line Antituberculous Drug Susceptibility

      Terminated
      • Tuberculosis, Pulmonary
      • +5 more
        • Bethesda, Maryland
        • +1 more
        Apr 4, 2018

        Accuracy and Feasibility of Xpert Ultra

        Completed
        • Tuberculosis, Pulmonary
        • Xpert MTB/RIF Ultra
        • Minsk, Belarus
        • +5 more
        Feb 6, 2018

        Tuberculosis, Tuberculosis, Pulmonary Trial in San Antonio (Sutezolid, Placebo)

        Completed
        • Tuberculosis
        • Tuberculosis, Pulmonary
        • San Antonio, Texas
          Worldwide Clinical Trials
        Feb 6, 2018

        Tuberculosis, Pulmonary Trial in South Africa, Tanzania (SQ109, Rifampicin, Moxifloxacin)

        Completed
        Has Results
        • Tuberculosis, Pulmonary
        • Bellville, South Africa
        • +6 more
        Aug 22, 2017

        Tuberculosis, Pulmonary, Latent Tuberculosis Trial in Seoul (Ultra low dose chest computed tomography (ULDCT), Chest X-ray,

        Unknown status
        • Tuberculosis, Pulmonary
        • Latent Tuberculosis
        • Ultra low dose chest computed tomography (ULDCT)
        • +2 more
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Jul 18, 2017

        Children With Suspected Latent or Active TB Infection

        Unknown status
        • Tuberculosis, Pulmonary
        • +2 more
        • IGRA test (QTF-GIT)
        • Grosseto, GR, Italy
        • +2 more
        May 4, 2017

        Tuberculosis, Pulmonary Trial in Singapore (11C-acetate ligand, FDG ligand)

        Unknown status
        • Tuberculosis, Pulmonary
        • 11C-acetate ligand
        • FDG ligand
        • Singapore, Singapore
        • +1 more
        Apr 12, 2017

        Tuberculosis, Pulmonary Trial in Kuala Lumpur, Manila, Singapore (Pascolizumab, Placebo)

        Unknown status
        • Tuberculosis, Pulmonary
        • Kuala Lumpur, Malaysia
        • +6 more
        Mar 30, 2017

        Tuberculosis, Pulmonary Trial in China (Isoniazid, Rifampicin, Pyrazinamide)

        Unknown status
        • Tuberculosis, Pulmonary
        • Hefei, Anhui, China
        • +34 more
        Mar 16, 2017

        Tuberculosis, Pulmonary Trial in Singapore (FDG ligand, DOTANOC ligand)

        Unknown status
        • Tuberculosis, Pulmonary
        • FDG ligand
        • DOTANOC ligand
        • Singapore, Singapore
        • +1 more
        Nov 16, 2016

        Probe Melting Technology for Rapid Detection of Drug Resistant

        Unknown status
        • Tuberculosis, Pulmonary
          • (no location specified)
          May 16, 2016